Fig. 5From: Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational studyPercentage of samples within the therapeutic range for TZP according to the different BP multiplications and renal functionBack to article page